Literature DB >> 29218663

Laparoscopic extended cholecystectomy for T3 gallbladder cancer.

Sungho Kim1, Yoo-Seok Yoon2, Ho-Seong Han1, Jai Young Cho1, YoungRok Choi1.   

Abstract

BACKGROUND: Gallbladder cancer (GBC) has been contraindicated for laparoscopic surgery since this procedure was introduced [1, 2]. Recently, however, there have been several reports of laparoscopic extended cholecystectomy for GBC, but most cases involved early GBC confined to the GB [3, 4]. This video describes our technique of laparoscopic extended cholecystectomy for T3 GBC.
METHODS: A 77-year-old female presented with a gallbladder mass, which was incidentally detected during evaluation of back pain. Abdominal computed tomography and endoscopic ultrasonography revealed a 3.5 × 2.5 cm hypoechoic mass in the gallbladder fundus with liver invasion. We performed laparoscopic en bloc resection of the gallbladder and the gallbladder bed, as well as lymphadenectomy.
RESULTS: Two 5-mm and three 12-mm trocars were used. After carefully dissecting Calot's triangle, the cystic duct was dissected and ligated. The cystic duct margin was negative on the frozen section biopsy. Cholecystectomy with en bloc wedge resection of the liver was performed first. Ultrasonic shears were used to transect the superficial hepatic parenchyma and a Cavitron Ultrasonic Surgical Aspirator was used to transect the deeper parenchyma. We then performed lymphadenectomy of involved lymph nodes (LNs) around the hepatoduodenal ligament, common hepatic artery, and posterior superior pancreas. After Kocherization of the duodenum, LNs were dissected from the posterior superior portion of the pancreas. LN dissection continued along the right side of the common bile duct and the portal vein. After dissection from the inferior vena cava and the aorta, the dissected LNs were pushed toward the left side under the portal vein. LN dissection continued along the left side of the hepatoduodenal ligament, while exposing the common hepatic artery and proper hepatic artery. Skeletonizing en bloc LN dissection was the final procedure. The operation time was 215 min and the estimated intraoperative blood loss was 200 mL. The postoperative pathology confirmed a small cell neuroendocrine carcinoma with clear resection margins. The pathologic staging was pT3N1. LN metastasis was found in one of 12 retrieved LNs. The patient was discharged on postoperative day 4 without postoperative complications. The patient received combined chemoradiation therapy for 6 months after surgery. There was no evidence of recurrence over the follow-up period of 14 months.
CONCLUSION: Laparoscopic extended cholecystectomy is technically feasible in patients with T3 GBC, and the extent of resection is the same as that of open surgery.

Entities:  

Keywords:  Extended cholecystectomy; Gallbladder cancer; Laparoscopy

Mesh:

Year:  2017        PMID: 29218663     DOI: 10.1007/s00464-017-5952-8

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  4 in total

1.  Is Laparoscopy Contraindicated for Gallbladder Cancer? A 10-Year Prospective Cohort Study.

Authors:  Yoo-Seok Yoon; Ho-Seong Han; Jai Young Cho; YoungRok Choi; Woohyung Lee; Jae Yool Jang; Hanlim Choi
Journal:  J Am Coll Surg       Date:  2015-07-20       Impact factor: 6.113

2.  Gallbladder cancer: role of laparoscopy in the management of potentially resectable tumors.

Authors:  Xabier de Aretxabala; Jorge Leon; Juan Hepp; Fernando Maluenda; Ivan Roa
Journal:  Surg Endosc       Date:  2010-02-23       Impact factor: 4.584

Review 3.  Laparoscopic cholecystectomy and gallbladder cancer.

Authors:  Ralf Steinert; Gerd Nestler; Emil Sagynaliev; Jörg Müller; Hans Lippert; Marc-André Reymond
Journal:  J Surg Oncol       Date:  2006-06-15       Impact factor: 3.454

4.  Gallbladder cancer discovered during laparoscopic surgery. Potential for iatrogenic tumor dissemination.

Authors:  Y Fong; M F Brennan; A Turnbull; D G Colt; L H Blumgart
Journal:  Arch Surg       Date:  1993-09
  4 in total
  4 in total

1.  Update in clinical management for gallbladder neuroendocrine carcinoma.

Authors:  Hongwu Chu; Ying Shi; Junwei Liu; Dongsheng Huang; Jungang Zhang; Changwei Dou
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

Review 2.  Robot-assisted radical cholecystectomy for gallbladder cancer: A review.

Authors:  Weng Jiayi; Vishal G Shelat
Journal:  J Clin Transl Res       Date:  2022-02-02

3.  Oncologic and Long-Term Outcomes of Laparoscopic and Open Extended Cholecystectomy for Gallbladder Cancer.

Authors:  Jong Woo Lee; Jae Hyun Kwon; Jung Woo Lee
Journal:  J Clin Med       Date:  2022-04-11       Impact factor: 4.241

Review 4.  Preoperative Assessment and Perioperative Management of Resectable Gallbladder Cancer in the Era of Precision Medicine and Novel Technologies: State of the Art and Future Perspectives.

Authors:  Gianluca Cassese; Ho-Seong Han; Yoo-Seok Yoon; Jun Suh Lee; Jai Young Cho; Hae-Won Lee; Boram Lee; Roberto Ivan Troisi
Journal:  Diagnostics (Basel)       Date:  2022-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.